Contact
searchSearch
HMP Global
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Phillip Gu
Video
Phillip Gu, MD, on Preventing Postoperative Crohn's Disease Recurrence
09/11/2024
Dr Gu reviews his address at the AIBD regional meeting on the recurrence of postoperative Crohn's disease, including how to assess risks and steps that can help to prevent it.
Dr Gu reviews his address at the AIBD regional meeting on the recurrence of postoperative Crohn's disease, including how to assess risks and steps that can help to prevent it.
Dr Gu reviews his address at the...
09/11/2024
Advances in Inflammatory Bowel Disease Network
Christina Ha
Video
Christina Ha, MD, on the Role of Anti-interleukins in IBD
09/10/2024
Dr Ha reviews her presentation from the AIBD regional on the safety and efficacy of interleukin 12/23 and interleukin 23 in the management of Crohn's disease and ulcerative colitis.
Dr Ha reviews her presentation from the AIBD regional on the safety and efficacy of interleukin 12/23 and interleukin 23 in the management of Crohn's disease and ulcerative colitis.
Dr Ha reviews her presentation...
09/10/2024
Advances in Inflammatory Bowel Disease Network
Florian Rieder
Video
Florian Rieder, MD, on Optimizing Outcomes in Crohn's Disease
08/21/2024
Dr Rieder reviews the options for treatment of Crohn's disease in terms of safety, treatment of comorbidities, and efficacy for moderate to severe disease.
Dr Rieder reviews the options for treatment of Crohn's disease in terms of safety, treatment of comorbidities, and efficacy for moderate to severe disease.
Dr Rieder reviews the options...
08/21/2024
Advances in Inflammatory Bowel Disease Network
Ray Cross
Conference Coverage
Raymond Cross, MD, on Drug Positioning in Crohn's Disease
08/08/2024
Dr Cross reviewed the options for treatment for Crohn's disease, including the many drug options now available and using comparative effectiveness to help positioning therapeutics.
Dr Cross reviewed the options for treatment for Crohn's disease, including the many drug options now available and using comparative effectiveness to help positioning therapeutics.
Dr Cross reviewed the options...
08/08/2024
Advances in Inflammatory Bowel Disease Network
Christina Ha
Conference Coverage
Christina Ha, MD, on Using Comparative Effectiveness Data in Treating Ulcerative Colitis
07/19/2024
“The safest treatment is often the treatment that effectively controls ulcerative colitis," Dr Christina Ha told the audience at the Advances in Inflammatory Bowel Disease regional meeting in Chicago, Illinois, July 19.
“The safest treatment is often the treatment that effectively controls ulcerative colitis," Dr Christina Ha told the audience at the Advances in Inflammatory Bowel Disease regional meeting in Chicago, Illinois, July 19.
“The safest treatment is often...
07/19/2024
Advances in Inflammatory Bowel Disease Network
Jessica Allegretti
Video
Jessica Allegretti, MD, on Recent Advances in Anti-Interleukin Therapies
07/19/2024
Dr Allegretti provides key take-home points from her presentation at the AIBD regional meeting on how anti-interleukin therapies work to treat both Crohn's disease and ulcerative colitis,
Dr Allegretti provides key take-home points from her presentation at the AIBD regional meeting on how anti-interleukin therapies work to treat both Crohn's disease and ulcerative colitis,
Dr Allegretti provides key...
07/19/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on the Potential of Interleukin Inhibitors in IBD
04/03/2023
Dr Long discusses her presentation at the Advances in Inflammatory Bowel Diseases regional meeting in Baltimore on the use of interleukin-12/23 and -23 inhibitors in the treatment of IBD.
Dr Long discusses her presentation at the Advances in Inflammatory Bowel Diseases regional meeting in Baltimore on the use of interleukin-12/23 and -23 inhibitors in the treatment of IBD.
Dr Long discusses her...
04/03/2023
Advances in Inflammatory Bowel Disease Network
Stefan Holubar
Video
Stefan Holubar, MD, on Perioperative Management of IBD
03/24/2023
Dr Holubar reviewed the key steps to preparing patients with inflammatory bowel disease for surgery to ensure the best possible outcomes at the Advances in Inflammatory Bowel Diseases virtual regional meeting April 20-21.
Dr Holubar reviewed the key steps to preparing patients with inflammatory bowel disease for surgery to ensure the best possible outcomes at the Advances in Inflammatory Bowel Diseases virtual regional meeting April 20-21.
Dr Holubar reviewed the key...
03/24/2023
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Conference Coverage
Maia Kayal, MD, on Interleukin-23s in IBD
09/30/2022
Dr Kayal discusses her presentation at the AIBD regional meeting on the efficacy and safety of IL-23 inhibitors in the treatment of inflammatory bowel disease.
Dr Kayal discusses her presentation at the AIBD regional meeting on the efficacy and safety of IL-23 inhibitors in the treatment of inflammatory bowel disease.
Dr Kayal discusses her...
09/30/2022
Advances in Inflammatory Bowel Disease Network
Christina Ha
Conference Coverage
Christina Ha, MD, on Positioning Therapies for Ulcerative Colitis
09/30/2022
Dr Ha reviews the key takeaways from her presentation at the Advances in Inflammatory Bowel Diseases regional meeting on choosing and positioning therapies for ulcerative colitis.
Dr Ha reviews the key takeaways from her presentation at the Advances in Inflammatory Bowel Diseases regional meeting on choosing and positioning therapies for ulcerative colitis.
Dr Ha reviews the key takeaways...
09/30/2022
Advances in Inflammatory Bowel Disease Network
Gil Y. Melmed, MD, on Strategies for Treating C. difficile in IBD
Videos
Gil Y. Melmed, MD, on Strategies for Treating C. difficile in IBD
04/16/2021
Dr Melmed, codirector of Clinical IBD at Cedars-Sinai in Los Angeles, reviews his presentation at the virtual Advances in Inflammatory Bowel Diseases regional meeting on April 16 concerning the treatment of C. difficile infection in patients...
Dr Melmed, codirector of Clinical IBD at Cedars-Sinai in Los Angeles, reviews his presentation at the virtual Advances in Inflammatory Bowel Diseases regional meeting on April 16 concerning the treatment of C. difficile infection in patients...
Dr Melmed, codirector of...
04/16/2021
Advances in Inflammatory Bowel Disease Network
Christina Ha, MD, on Managing IBD Care for the Young Adult
Videos
Christina Ha, MD, on Managing IBD Care for the Young Adult
04/15/2021
In this video, Dr Ha, from the IBD Center at Cedars-Sinai in Los Angeles, gives an overview of her recent presentation to the Advances in Inflammatory Bowel Diseases 2021 virtual regional meeting on how to prepare young patients with IBD,...
In this video, Dr Ha, from the IBD Center at Cedars-Sinai in Los Angeles, gives an overview of her recent presentation to the Advances in Inflammatory Bowel Diseases 2021 virtual regional meeting on how to prepare young patients with IBD,...
In this video, Dr Ha, from the...
04/15/2021
Advances in Inflammatory Bowel Disease Network
Expert Perspectives: The Future of Small Molecules in IBD Treatment
Conference Coverage
Expert Perspectives: The Future of Small Molecules in IBD Treatment
03/06/2021
David Rubin, MD, from the University of Chicago, gave a preview of therapies coming soon that could improve treatment for patients with ulcerative colitis and Crohn disease at the Advances in Inflammatory Bowel Diseases 2021 virtual regional...
David Rubin, MD, from the University of Chicago, gave a preview of therapies coming soon that could improve treatment for patients with ulcerative colitis and Crohn disease at the Advances in Inflammatory Bowel Diseases 2021 virtual regional...
David Rubin, MD, from the...
03/06/2021
Advances in Inflammatory Bowel Disease Network
Management of Infections in the Immunosuppressed Patient With IBD
Conference Coverage
Management of Infections in the Immunosuppressed Patient With IBD
03/06/2021
Jessica Allegretti, MD, presented on the importance of testing for and treatment of infections in immunosuppressed patients with IBD at the Advances in Inflammatory Bowel Diseases 2021 virtual regional meeting on March 6.
Jessica Allegretti, MD, presented on the importance of testing for and treatment of infections in immunosuppressed patients with IBD at the Advances in Inflammatory Bowel Diseases 2021 virtual regional meeting on March 6.
Jessica Allegretti, MD,...
03/06/2021
Advances in Inflammatory Bowel Disease Network
Diet Can Provide Symptom Management for Patients with IBD
Conference Coverage
Diet Can Provide Symptom Management for Patients with IBD
03/06/2021
Millie D. Long, MD, discusses how diet can function as adjunctive treatment for managing symptoms among patients with inflammatory bowel disease.
Millie D. Long, MD, discusses how diet can function as adjunctive treatment for managing symptoms among patients with inflammatory bowel disease.
Millie D. Long, MD, discusses...
03/06/2021
Advances in Inflammatory Bowel Disease Network
Earlier Is Better: Optimal Use of Anti-IL 12/23 Agents
Conference Coverage
Earlier Is Better: Optimal Use of Anti-IL 12/23 Agents
03/06/2021
David Rubin, MD, reviewed the trial data and the best positioning for ustekinumab in treating inflammatory bowel disease and discussed promising newcomers to the class at the virtual Advances in Inflammatory Bowel Diseases 2021 regional...
David Rubin, MD, reviewed the trial data and the best positioning for ustekinumab in treating inflammatory bowel disease and discussed promising newcomers to the class at the virtual Advances in Inflammatory Bowel Diseases 2021 regional...
David Rubin, MD, reviewed the...
03/06/2021
Advances in Inflammatory Bowel Disease Network
The Optimal Use of JAK inhibitors: Risks, Benefits, and the Role of Selectivity
Conference Coverage
The Optimal Use of JAK inhibitors: Risks, Benefits, and the Role of Selectivity
03/06/2021
Millie Long, MD, from the University of North Carolina, discussed the risks and benefits of using Janus kinase inhibitors to help control inflammation in inflammatory bowel disease.
Millie Long, MD, from the University of North Carolina, discussed the risks and benefits of using Janus kinase inhibitors to help control inflammation in inflammatory bowel disease.
Millie Long, MD, from the...
03/06/2021
Advances in Inflammatory Bowel Disease Network

Latest Podcasts

Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use